Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathway
(2017) In Scientific Reports 7(1).- Abstract
Hypertension is a dominating risk factor for cardiovascular disease. To characterize the genomic response to hypertension, we administered vehicle or angiotensin II to mice and performed gene expression analyses. AngII treatment resulted in a robust increase in blood pressure and altered expression of 235 genes in the aorta, including Gucy1a3 and Gucy1b3 which encode subunits of soluble guanylyl cyclase (sGC). Western blotting and immunohistochemistry confirmed repression of sGC associated with curtailed relaxation via sGC activation. Analysis of transcription factor binding motifs in promoters of differentially expressed genes identified enrichment of motifs for RBPJ, a component of the Notch signaling pathway, and the Notch... (More)
Hypertension is a dominating risk factor for cardiovascular disease. To characterize the genomic response to hypertension, we administered vehicle or angiotensin II to mice and performed gene expression analyses. AngII treatment resulted in a robust increase in blood pressure and altered expression of 235 genes in the aorta, including Gucy1a3 and Gucy1b3 which encode subunits of soluble guanylyl cyclase (sGC). Western blotting and immunohistochemistry confirmed repression of sGC associated with curtailed relaxation via sGC activation. Analysis of transcription factor binding motifs in promoters of differentially expressed genes identified enrichment of motifs for RBPJ, a component of the Notch signaling pathway, and the Notch coactivators FRYL and MAML2 were reduced. Gain and loss of function experiments demonstrated that JAG/NOTCH signaling controls sGC expression together with MAML2 and FRYL. Reduced expression of sGC, correlating with differential expression of MAML2, in stroke prone and spontaneously hypertensive rats was also seen, and RNA-Seq data demonstrated correlations between JAG1, NOTCH3, MAML2 and FRYL and the sGC subunits GUCY1A3 and GUCY1B3 in human coronary artery. Notch signaling thus provides a constitutive drive on expression of the major nitric oxide receptor (GUCY1A3/GUCY1B3) in arteries from mice, rats, and humans, and this control mechanism is disturbed in hypertension.
(Less)
- author
- Rippe, Catarina LU ; Zhu, Baoyi LU ; Krawczyk, Katarzyna K. LU ; van Bavel, Ed ; Albinsson, Sebastian LU ; Sjölund, Jonas LU ; Bakker, Erik N T P and Swärd, Karl LU
- organization
- publishing date
- 2017-05-02
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Scientific Reports
- volume
- 7
- issue
- 1
- article number
- 1334
- publisher
- Nature Publishing Group
- external identifiers
-
- pmid:28465505
- wos:000400449700009
- scopus:85018280054
- ISSN
- 2045-2322
- DOI
- 10.1038/s41598-017-01392-1
- language
- English
- LU publication?
- yes
- id
- 44d8a8ed-a8a4-499c-99db-bb2c61ea21d4
- date added to LUP
- 2017-05-17 08:16:31
- date last changed
- 2024-10-14 06:16:22
@article{44d8a8ed-a8a4-499c-99db-bb2c61ea21d4, abstract = {{<p>Hypertension is a dominating risk factor for cardiovascular disease. To characterize the genomic response to hypertension, we administered vehicle or angiotensin II to mice and performed gene expression analyses. AngII treatment resulted in a robust increase in blood pressure and altered expression of 235 genes in the aorta, including Gucy1a3 and Gucy1b3 which encode subunits of soluble guanylyl cyclase (sGC). Western blotting and immunohistochemistry confirmed repression of sGC associated with curtailed relaxation via sGC activation. Analysis of transcription factor binding motifs in promoters of differentially expressed genes identified enrichment of motifs for RBPJ, a component of the Notch signaling pathway, and the Notch coactivators FRYL and MAML2 were reduced. Gain and loss of function experiments demonstrated that JAG/NOTCH signaling controls sGC expression together with MAML2 and FRYL. Reduced expression of sGC, correlating with differential expression of MAML2, in stroke prone and spontaneously hypertensive rats was also seen, and RNA-Seq data demonstrated correlations between JAG1, NOTCH3, MAML2 and FRYL and the sGC subunits GUCY1A3 and GUCY1B3 in human coronary artery. Notch signaling thus provides a constitutive drive on expression of the major nitric oxide receptor (GUCY1A3/GUCY1B3) in arteries from mice, rats, and humans, and this control mechanism is disturbed in hypertension.</p>}}, author = {{Rippe, Catarina and Zhu, Baoyi and Krawczyk, Katarzyna K. and van Bavel, Ed and Albinsson, Sebastian and Sjölund, Jonas and Bakker, Erik N T P and Swärd, Karl}}, issn = {{2045-2322}}, language = {{eng}}, month = {{05}}, number = {{1}}, publisher = {{Nature Publishing Group}}, series = {{Scientific Reports}}, title = {{Hypertension reduces soluble guanylyl cyclase expression in the mouse aorta via the Notch signaling pathway}}, url = {{http://dx.doi.org/10.1038/s41598-017-01392-1}}, doi = {{10.1038/s41598-017-01392-1}}, volume = {{7}}, year = {{2017}}, }